Pivotal bioVenture Partners China
Shanghai, Shanghaipivotalbiovp.com
Overview
Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences, is a venture capital firm specializing in venture building in the life sciences industry. Its investment strategy is centered on identifying promising innovative products and technologies and bringing them to serve the growing unmet medical needs in Greater China region by building new ventures. Its investment areas include therapeutics, medical devices and medical services. The Pivotal China team includes experienced life science investors and entrepreneurs with successful track records of venture building and investing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| HerAnova Lifesciences | Dec 2023 | Seed | Co-investor |
| Plexium | Feb 2022 | Series B | Co-investor |
| Arkuda Therapeutics | Feb 2022 | Series B | Lead |
| Ablaze Pharmaceuticals | Nov 2021 | Series A | Co-investor |
| Arctic Vision | Mar 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.